| Sandoz Pharmaceuticals AG - Tapentadol Sandoz Retard 250 mg, Retardtabletten | | 68784 | | 06 | | Tapentadol Sandoz Retard 250 mg | | Retardtabletten | | N02AX06 | | Tapentadol | | 02.08.2023 | | |
| | Composition | | tapentadolum 250 mg ut tapentadoli phosphas, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, glycerolum, talcum, cellulosum microcristallinum, E 171, E 172 (rubrum), E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Delayed release tablets | | | | Active Agent | Dose |
|---|
| Tapentadolum | 250 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Glycerol | | | | Hypromellosum | | Überzug | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 011 | 30 | PR | PR | A+ | | No | | 012 | 60 | PR | PR | A+ | | No |
|
|
